Jazz Pharmaceuticals

Yahoo Finance • 6 hours ago

3 Healthcare Stocks We Think Twice About

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destocking have persisted in the wake of COVID-19, limiting growth. This has capped... Full story

Yahoo Finance • 5 days ago

3 Mid-Cap Stocks We’re Skeptical Of

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupte... Full story

Yahoo Finance • 6 days ago

Banking giant massively resets Jazz Pharma stock price target

Changes in Wall Street price targets usually arrive in small increments. A few dollars up, a few dollars down, and sometimes a rating left untouched. UBS skipped that script with Jazz Pharmaceuticals (JAZZ). On May 19, UBS analyst Ashwan... Full story

Yahoo Finance • 9 days ago

JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms

Investing.com -- JPMorgan has reinstated ratings and price targets on 14 large-cap biotechnology companies, describing the sector as being at a critical “inflection point” as pipeline successes increasingly translate into profitable commer... Full story

Yahoo Finance • 9 days ago

Is Marriott Stock a Buy After GMT Capital Initiated a Position Worth Over $66 Million?

What happened According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, GMT Capital Corp. established a new position in Marriott Vacations Worldwide Corporation(NYSE:VAC) during the first quarter, acquiring 1,023,... Full story

Yahoo Finance • 10 days ago

StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Guggenheim upgraded StubHub (STUB) to... Full story

Yahoo Finance • 11 days ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More

Quick Read: The trading week started mixed as many of the same issues we saw last Friday remained front and center on Monday. There is a rumbling in the bond market that new Federal Reserve Chairman Kevin Warsh may have to raise rates thi... Full story

Yahoo Finance • last month

How ASCO Phase 3 Oncology Data May Reshape Jazz Pharmaceuticals' (JAZZ) Investment Narrative

Jazz Pharmaceuticals recently announced that it and its partners will present three rapid oral and seven poster oncology data sets at the 2026 ASCO Annual Meeting in Chicago, including Phase 3 results for Ziihera (zanidatamab-hrii) in HER2... Full story

Yahoo Finance • last month

Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Jazz Pharmaceuticals (NASDAQ:JAZZ) and the best and worst performers in the pharma... Full story

Yahoo Finance • last month

Barclays Raises its Price Target on Jazz Pharmaceuticals (JAZZ) to $225

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is one of the 10 Best Fast Growth Stocks to Invest In Now. On April 19, 2026, Barclays analyst Etzer Darout raised the price target on Jazz Pharmaceuticals plc (NASDAQ:JAZZ) to $225 from $224 and ma... Full story

Yahoo Finance • last month

3 Overrated Stocks with Warning Signs

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds. But not every company... Full story

Yahoo Finance • last month

Tuberous Sclerosis Complex Market Research and Global Long-term Forecast Report 2026-2035 Featuring Prominent Players - Novartis, Jazz Pharmaceuticals, Nobelpharma America

Company Logo The global tuberous sclerosis complex market is set for substantial growth, driven by increased awareness and advancements in treatment options such as everolimus and cannabidiol. These innovations address conditions like sei... Full story

Yahoo Finance • last month

Stock Market Today: Chips Outperform As AMD Breaks Out; Abbott Labs Hits Multiyear Low (Live Coverage)

Stock Market Today: The Dow Jones index swings Thursday after an unexpected result in jobless claims data. Netflix earnings are due late. Continue Reading... Full story

Yahoo Finance • 2 months ago

Nike downgraded, IBM initiated: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Mizuho upgraded Shake Shack(SHAK) to O... Full story

Yahoo Finance • 2 months ago

Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says

Large-cap and small- to medium-cap biopharmaceutical companies in BofA Securities' coverage are not PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 3 months ago

3 Healthcare Stocks Walking a Fine Line

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have realized strong financial performance, and over the past six months, the industry’s 3.8%... Full story

Yahoo Finance • 3 months ago

Taco Bell Parent, Data Center Play And Two Other Stocks Weather War Storm, Hover Near Highs

Building construction play Argan and three other stocks are notable for scoring new highs amid recent market volatility. Argan touched an all-time high of 469.88 in Wednesday's stock market before pulling back to its 21-day moving average.... Full story

Yahoo Finance • 3 months ago

Global Nanomedicine Market is Projected to Cross the USD 550 Billion Mark by 2034 as Advanced Drug Delivery Technologies Accelerate Adoption | DelveInsight

The nanomedicine market is largely propelled by the increasing demand for precise and more effective treatments, especially for cancer, cardiovascular conditions, and other chronic diseases, where traditional medications are often limited... Full story

Yahoo Finance • 3 months ago

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight

LAS VEGAS, March 2, 2026 /PRNewswire/ -- The biliary tract cancer market is experiencing steady growth driven by rising global incidence and improved diagnostic capabilities. Increasing adoption of targeted therapies and immuno-oncology ap... Full story

Yahoo Finance • 3 months ago

Zymeworks Q4 Earnings Call Highlights

Zymeworks logo Zymeworks Offers Hope for More than Just Long-Term Investors Zymeworks (NASDAQ:ZYME) executives used the company’s fourth-quarter 2025 results call to highlight updated clinical data for its partnered HER2 antibody zanidat... Full story